Skip to main content
TipRanks
Go Ultimate75% OFF

Ultragenyx Pharmaceutical (0LIF) Income Statement

0 Followers

Ultragenyx Pharmaceutical Income Statement

Last quarter (Q3 2026), Ultragenyx Pharmaceutical's total revenue was $173.00M, an increase of 8.17% from the same quarter last year. In Q3, Ultragenyx Pharmaceutical's net income was $-118.00M. See Ultragenyx Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 673.00M$ 560.23M$ 434.25M$ 363.33M$ 351.41M
$ 564.00M$ 483.50M$ 389.04M$ 335.01M$ 335.40M
$ 1.10B$ 1.02B$ 958.25M$ 983.93M$ 717.13M
Depreciation and Amortization$ 35.00M$ 35.54M$ 26.01M$ 18.22M$ 13.24M
$ -474.00M$ -469.00M$ -516.45M$ -640.49M$ -410.32M
$ -535.00M$ -535.97M$ -569.21M$ -648.92M$ -381.74M
$ -36.00M$ -31.61M$ -39.26M$ -52.81M$ -71.24M
$ -571.00M$ -567.59M$ -608.46M$ -701.73M$ -452.98M
$ -575.00M$ -569.18M$ -606.64M$ -707.42M$ -454.02M
Per Share Metrics
Basic EPS$ -5.83$ -6.29$ -8.25$ -10.12$ -6.70
Diluted EPS$ -5.83$ -6.29$ -8.25$ -10.12$ -6.70
Weighted Average Shares Outstanding98.60M90.54M73.54M69.91M67.80M
Weighted Average Shares Outstanding (Diluted)98.60M90.54M73.54M69.91M67.80M

Currency in USD

Ultragenyx Pharmaceutical Earnings and Revenue History

-800M0800M1.6B-15000 %-10000 %-5000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin